R1	Has_qualifier Arg1:T1 Arg2:T2	
R2	Has_multiplier Arg1:T3 Arg2:T4	
R3	AND Arg1:T5 Arg2:T6	
R4	Has_value Arg1:T7 Arg2:T8	
*	OR T7 T9
R5	Has_qualifier Arg1:T10 Arg2:T11	
*	OR T10 T12
R6	Has_index Arg1:T15 Arg2:T16	
R7	Has_temporal Arg1:T14 Arg2:T15	
R8	Has_negation Arg1:T19 Arg2:T20	
R9	AND Arg1:T18 Arg2:T19	
R10	Has_index Arg1:T21 Arg2:T24	
R11	Has_index Arg1:T22 Arg2:T23	
*	OR T21 T22
*	OR T17 T18
R12	Has_temporal Arg1:T17 Arg2:T21	
*	OR T28 T29 T30 T31 T32 T33
R13	Subsumes Arg1:T27 Arg2:T28	
T1	Procedure 25 45	coronary angiography
T2	Qualifier 9 24	diagnostic-only
T3	Drug 50 60	colchicine
T4	Multiplier 61 72	chronically
T5	Condition 85 96	intolerance
T6	Drug 100 110	colchicine
T7	Measurement 112 138	Glomerular filtration rate
T8	Value 139 151	<30mL/minute
T9	Procedure 158 166	dialysis
T10	Condition 175 185	malignancy
T11	Qualifier 168 174	Active
T12	Condition 189 198	infection
T13	Condition 211 225	myelodysplasia
T14	Drug 227 243	High-dose statin
T15	Temporal 249 277	<24 hours prior to procedure
T16	Reference_point 268 277	procedure
T17	Drug 286 299	oral steroids
T18	Drug 303 341	non-steroidal anti-inflammatory agents
T19	Drug 353 360	aspirin
T20	Negation 342 352	other than
T21	Temporal 361 376	within 72 hours
T22	Temporal 361 367;380 409	within 3 times the agent's half-life
T23	Reference_point 380 409	3 times the agent's half-life
T24	Reference_point 368 376	72 hours
T27	Drug 440 479	strong CYP3A4/P-glycoprotein inhibitors
T28	Drug 494 503	ritonavir
T29	Drug 505 517	ketoconazole
T30	Drug 519 533	clarithromycin
T31	Drug 535 547	cyclosporine
T32	Drug 549 558	diltiazem
T33	Drug 563 572	verapamil
T35	Non-query-able 575 592	Unable to consent
T36	Non-query-able 594 628	Participating in a competing study
